<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The hypothesis of dopamine hypersensitivity proposes that the nigrostriatal dopamine system develops increased sensitivity to dopamine as a consequence of chronic dopamine receptor blockade induced by neuroleptic drugs. There is an increased incidence and prevalence of involuntary hyperkinetic dyskinesia in patients receiving dopamine antagonists in most [
 <xref ref-type="bibr" rid="B1" class="xref">1</xref>-
 <xref ref-type="bibr" rid="B3" class="xref">3</xref>] but not all reports [
 <xref ref-type="bibr" rid="B4" class="xref">4</xref>,
 <xref ref-type="bibr" rid="B5" class="xref">5</xref>]. Dopamine antagonists usually suppress TD, whereas dopamine agonists aggravate TD symptoms [
 <xref ref-type="bibr" rid="B6" class="xref">6</xref>].
</p>
